my timesThe Korea Times
South Korea

Health

Korea Times
About Us
Introduction
History
Contact Us
Products & Services
Subscribe
E-paper
RSS Service
Content Sales
Site Map
Policy
Code of Ethics
Ombudsman
Privacy Policy
Youth Protection Policy
Terms of Service
Copyright Policy
Family Site
Hankookilbo
Dongwha Group
FacebookXYoutubeInstagram
CEO & Publisher: Oh Young-jinDigital News Email: webmaster@koreatimes.co.krTel: 02-724-2114Online newspaper registration No: 서울,아52844Date of registration: 2020.02.05Masthead: The Korea TimesCopyright © koreatimes.co.kr. All rights reserved.

Over 10,000 illegal immigrants leave Korea through crackdown

Groups of foreign workers wait for buses at Incheon International Airport, July 7. YonhapMore than 10,000 illegal immigrants left Korea through a crackdown and the voluntary departure program in October and November, the Ministry of Justice said Wednesday.The government has resumed its crackdown on foreigners staying or working illegally here since October after a pause due to COVID-19, the ministry said.The crackdown was mainly conducted in fields that can cause social harm, such as entertainment and massage services, and in industries closely linked to local people's jobs, such as logistics and delivery, it noted.Immigrant workers in Korea wait to receive a COVID-19 vaccine shot in Seoul in this Sept. 5, 2021 file photo. NewsisA total of 3,865 illegal immigrants were caught in the crackdown and 3,281 of them were forced or ordered to leave the country, the ministry said. By nationality, Thailand had the most at 1,441, followed by Vietnam with 814, China with 587 and Mongolia with 165.The ministry said an additional 7,378 illegal immigrants left the country through the voluntary dep

Dec 14, 2022
Over 10,000 illegal immigrants leave Korea through crackdown

Health authorities issue emergency order to produce more cold medicine

The Ministry of Food and Drug Safety in Osong, 111 kilometers south of Seoul / Courtesy of Ministry of Food and Drug SafetyKorea's health authorities have issued an emergency order to local pharmaceutical firms to increase production of acetaminophen tablets in a bid to tackle a cold medicine shortage in the winter season, government officials said Wednesday.The Ministry of Food and Drug Safety on Nov. 30 designated 650 milligram tablets of acetaminophen, medication used to treat fever and mild to moderate pain under the brand name Tylenol, as a crisis management medical product and ordered 18 pharmaceutical companies to produce and import more of it, according to the officials.The order will be effective through April and companies should report the production, import, sales and inventory of the medicine to the ministry on a monthly basis, the ministry added.The move came after the government announced plans to fill a shortage of fever reducers and pain relievers last month.According to the government plan, the monthly supply of 650 milligram tablets of acetaminophen will be increas

Dec 14, 2022
Health authorities issue emergency order to produce more cold medicine

Farm ministry expands poultry culling in avian influenza-hit South Jeolla Province

A quarantine vehicle disinfects areas in Hampyeong in South Jeolla Province, Dec. 5, after a highly pathogenic strain of H5N1 of avian influenza was found. YonhapThe agriculture ministry said Sunday it has expanded the scope of poultry culling at farms infected with a highly pathogenic avian influenza in some areas of South Jeolla Province.The move came as a total of 19 cases have been reported in the province since Nov. 16, when a highly pathogenic avian influenza was found at a duck farm in Jangheung, 394 kilometers southwest of Seoul.The ministry said the poultry culling has been expanded to 2 kilometers from the current 500 meters from an avian influenza-hit farm in Muan and Hampyeong in the province.Earlier in the day, Agriculture Minister Chung Hwang-keun visited a disinfection center in the province to inspect quarantine measures, the ministry said. (Yonhap)

Dec 11, 2022
Farm ministry expands poultry culling in avian influenza-hit South Jeolla Province

Korea's new COVID-19 cases over 60,000 for 5th day,

A public health facility for coronavirus tests set up in Seoul's Yongsan District, Dec. 9. YonhapNew COVID-19 cases stayed above 60,000 here for the fifth consecutive day Friday amid lingering concerns of another surge as the government mulls easing its indoor mask mandate.The country reported 62,738 new COVID-19 infections, including 61 from overseas, bringing the cumulative total to 27,674,163, the Korea Disease Control and Prevention Agency (KDCA) said. Friday's tally is slightly higher than the previous day's 62,734 and over 9,000 higher than a week earlier, KDCA data showed. The government earlier said it will decide whether to lift the indoor mask mandate, the country's last remaining COVID-19 restriction, by the end of this month, based on various factors, including caseloads, deaths and hospitalizations. Daily caseloads are expected to continue on a slow incremental trend for the time being. The KDCA, however, did not rule out the possibility of another virus wave this winter. The country added 54 COVID-19 deaths, bringing the toll to 31,029. The number of critically ill pati

Dec 10, 2022
Korea's new COVID-19 cases over 60,000 for 5th day,

SK Biopharm's anti-epilepsy treatment wins sales approval in France

SK Biopharmaceuticals CEO Cho Jeong-woo speaks during an online press conference on the company's initial public offering, Monday, June 15, 2020. Courtesy of SK BiopharmaceuticalsSK Biopharmaceuticals, a pharmaceutical affiliate of Korea's SK Group, said Friday that its anti-epilepsy treatment is now available in France.Its European partner Angelini Pharma, a pharmaceutical unit under the Italian Angelini Industries, has won the sales approval from the French drug authorities for cenobamate under the brand name Ontozry, according to SK Biopharm.The Korean company said the drug, which was approved for medical use by the European Commission last year, is now on sale in five European countries, including Germany, Britain, Italy and Spain.The five countries account for about 73 percent of the total value of the continent's epilepsy market, it added.Cenobamate, discovered by SK Biopharmaceuticals and its U.S. subsidiary SK Life Science, is the treatment of partial-onset seizures in adults. It is sold under the brand names Xcopri in the United States. (Yonhap)

Dec 9, 2022
SK Biopharm's anti-epilepsy treatment wins sales approval in France

New COVID-19 cases over 60,000 for fourth day as virus continues to spread

A poster on the entrance door to a bookstore in Seoul instructs visitors to wear a face mask, Dec. 7. Yonhap Korea's new COVID-19 cases continued their weekly climb Friday, as the government mulls adjusting the indoor mask mandate even as the virus spreads.The country reported 62,734 new COVID-19 infections, including 50 from overseas, bringing the total to 27,611,555, the Korea Disease Control and Prevention Agency (KDCA) said. Friday's tally is slightly lower than the previous day's 65,253, but up by more than 9,700 from the same day a week earlier, and more than 9,000 higher than two weeks earlier, KDCA data showed. The Korean government said it will decide whether to lift the indoor mask mandate, the country's last remaining COVID-19 restriction, by the end of this month, based on various factors, including caseloads, deaths and hospitalizations. Daily caseloads are expected to continue on a slow incremental trend for the time being. The KDCA, however, did not r

Dec 9, 2022
New COVID-19 cases over 60,000 for fourth day as virus continues to spread

Bio industry will continue to see export boom next year: think tank

gettyimagesbankBy Lee Hyo-jin Triggered by the COVID-19 pandemic, Korea's bio-health industry has been enjoying an export boom in vaccines and diagnostic kits. This trend is expected to continue throughout next year, according to the Korea Health Industry Development Institute (KHIDI).According to the institute's report published Wednesday, the exports in the bio-health industry ― such as pharmaceuticals, medical devices and cosmetics ― are expected to hit $25.4 billion this year, a 0.3-percent increase from the previous year. The institute projected next year's export to hit $26.9 billion, up 5.4 percent from 2022.In 2022, exports to the Asia-Pacific region accounted for about 50.3 percent of the entire export volume of biopharmaceuticals, with Europe and North America taking up 25 percent and 15.7 percent, respectively. There would be no major changes in these figures in 2023, the report said.By product category, in 2023, export of pharmaceuticals are projected to surge by 15.5 percent year-on-year to reach $10.1 billion, cosmetics to $8.8 billion, up 6.7 percent, while the export

Dec 9, 2022By Lee Hyo-jin
Bio industry will continue to see export boom next year: think tank

Health ministry to review 'Mooncare,' adopt stricter measures for foreign dependents

Health minister Cho Kyu-hong delivers an opening speech at a public hearing held on measures to enhance health insurance sustainability and support essential medical care at a hotel in Seoul, Thursday. YonhapBy Lee Hyo-jin The Ministry of Health and Welfare will apply stricter standards on insurance coverage in Magnetic Resonance Imaging (MRI) checkups and ultrasound scans, undoing the healthcare insurance expansion policies adopted by the previous Moon Jae-in administration. The government will also adopt tougher measures to screen health insurance coverage of foreign residents' dependents by obligating them to reside continuously in Korea for at least six months in order to become eligible for the state healthcare program.The health authorities will also come up with ways to limit coverage for those who are suspected of reaping healthcare benefits by conducting unnecessary examinations or consultations.These measures intending to overhaul much of the health insurance policies introduced by the previous Moon administration ― dubbed “Mooncare,” which aimed to strengthen K

Dec 8, 2022By Lee Hyo-jin
Health ministry to review 'Mooncare,' adopt stricter measures for foreign dependents

Korea's new COVID-19 cases below 70,000

People wait in line to get tested for the coronavirus at a COVID-19 testing center in Seoul, Dec. 8. YonhapKorea's new COVID-19 cases slightly dropped Thursday, as the government is considering adjusting the indoor mask mandate. The country reported 65,253 new COVID-19 infections, including 48 from overseas, bringing the total to 27,548,821, the Korea Disease Control and Prevention Agency (KDCA) said. Thursday's tally is slightly lower than the previous day, but up by more than 8,000 from the same day a week earlier, and over 6,000 higher than two weeks earlier, KDCA data showed. Health authorities have said daily caseloads are expected to continue on a slow incremental trend for the time being, but warned the KDCA will not rule out the possibility of another virus wave this winter. The country added 61 COVID-19 deaths, bringing the death toll to 30,908. The number of critically ill patients stood at 435, down six from the previous day. The KDCA is scheduled to discuss adjustments to the indoor mask mandate on Friday and comes up with a final plan by the end of this month. The indoor

Dec 8, 2022
Korea's new COVID-19 cases below 70,000

Lifting of indoor mask mandate gains momentum

People wearing masks at a shopping mall in Seoul, Wednesday. NewsisBy Lee Hae-rinThe government will decide whether to ease the indoor mask mandate no later than March next year, health authorities said, Wednesday.Interior and Safety Minister Lee Sang-min, who is also the second deputy head of the Central Disease Management Headquarters, said during a meeting at Seoul Government Complex, Wednesday, that the government will “map out a final plan” concerning the lifting of the indoor mask mandate by the end of this month.The government will consult with specialists and hold an open debate on Dec. 15 before setting up the final plan, Lee explained. Since early November, health authorities mentioned the possibility of lifting the indoor mask mandate after a resurgence of coronavirus infections this winter.The government will decide whether to ease the indoor mask mandate sometime “between next January and March, at the latest,” Peck Kyong-ran, commissioner of the Korea Disease Control and Prevention Agency (KDCA), said.Some facilities could remain subject to the i

Dec 7, 2022By Lee Hae-rin
Lifting of indoor mask mandate gains momentum
previous page
9091929394
next page

Most Read in South Korea